Smith G W, McArthur C J, Simpson I J
J Clin Lab Immunol. 1983 Dec;12(4):197-9.
Thirty-one patients with proven acute myocardial infarction (MI) were studied prospectively at the time of admission to hospital and at 3, 7 and 18 days using 4 immune complex (IC) assays. Each assay showed an increased incidence of IC activity in MI with 76% of patients being positive in at least 1 assay on one or more of the sampling days. A positive IC assay did not show a significant correlation with cardiac failure, pericarditis, post MI syndrome or previous infarction. The presence of IC was found to correlate with serum C-reactive protein (CRP), serum enzymes and ESR and suggested that complexed CRP or other acute phase proteins may account for some of the IC activity found with less specific assays. The measurement of IC levels in MI has not proved helpful in the diagnosis, management or prediction of outcome in this disorder.
31例经证实的急性心肌梗死(MI)患者在入院时以及入院后第3天、第7天和第18天接受了前瞻性研究,采用了4种免疫复合物(IC)检测方法。每种检测方法都显示MI患者中IC活性的发生率增加,76%的患者在至少一个采样日的至少一种检测方法中呈阳性。IC检测呈阳性与心力衰竭、心包炎、心肌梗死后综合征或既往梗死无显著相关性。发现IC的存在与血清C反应蛋白(CRP)、血清酶和血沉率相关,提示复合的CRP或其他急性期蛋白可能是一些特异性较低的检测方法所发现的IC活性的部分原因。在MI中测量IC水平对该疾病的诊断、管理或预后预测并无帮助。